The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease: a cohort study

Infliximab treatment combined with partial enteral nutrition is beneficial for both short-term clinical response and long-term endoscopic remission in CD patients.

Authors

Institutions

Publication Details

Journal
Frontiers in Nutrition
Published
2025-06-18
DOI
https://doi.org/10.3389/fnut.2025.1591954
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease: a cohort study

Hao Wu, Baixue Zhuo, Shu­zhong Bai, Weixiang Yao et al.
Frontiers in Nutrition
Inflammatory Bowel Disease
article

The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease: a cohort study

Hao Wu, Baixue Zhuo, Shu­zhong Bai, Weixiang Yao, Xiaoli Wu, Chao Chen, Chen Huang, Hanyu Yin
article en

Abstract

Infliximab treatment combined with partial enteral nutrition is beneficial for both short-term clinical response and long-term endoscopic remission in CD patients.

Frontiers in NutritionVol. 12
Wenzhou Medical University (CN), First Affiliated Hospital of Wenzhou Medical University (CN), People’s Hospital of Wenshan Prefecture (CN), Wenzhou City People's Hospital (CN)
Zero hunger
Openalex Percentile: Top 84%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.